What Will Be the Impact of Erythropoietin on Chronic Dialysis?
- 1 April 1989
- journal article
- Published by Wiley in Seminars in Dialysis
- Vol. 2 (2) , 75-77
- https://doi.org/10.1111/j.1525-139x.1989.tb00559.x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.Proceedings of the National Academy of Sciences, 1988
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- IMPROVEMENT IN THE HAEMOSTATIC DEFECT OF URAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETINThe Lancet, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987